Yintao Zhang 1 , 2 ,† , Xichen Lian 1 ,† , Hangwei Xu 1 ,† , Sisi Zhu 3 , Hao Zhang 3 , Ziheng Ni 3 , Tingting Fu 1 , Shuiping Liu 3 , Lin Tao 3 , * , Ying Zhou 1 , * and Feng Zhu 1 , 2 , * 1 College of Pharmaceutical Sciences, Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China 2 Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Hangzhou 330110, China 3 Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China * To whom correspondence should be addressed. Tel: +86 189 8946 6518; Email: zhufeng@zju.edu.cn Correspondence may also be addressed to Prof. Ying Zhou. Email: zhou_ying@zju.edu.cn Correspondence may also be addressed to Prof. Lin Tao. Email: taolin@hznu.edu.cn † The first three authors should be regarded as Joint First Authors.